October 3, 2018 06:22 PM EDTUpdated October 4, 10:18 AM

Sarepta shares yo-yo in the red on another glimpse of stellar results for Duchenne MD gene therapy — what gives?

There’s just no telling what a stock will do — even when you stack the deck in your favor.

Tonight Sarepta $SRPT came out with a …

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE LOG IN

ENDPOINTS CAREERS

view job offer post your job now

TRENDING NOW

Sarep­ta shares yo-yo in the red on an­oth­er glimpse of stel­lar re­sults for Duchenne MD gene ther­a­py — what gives?